Literature DB >> 24604352

Inhibiting mast cell degranulation by HO-1 affects dendritic cell maturation in vitro.

Yuan-yuan Ma1, Mu-qing Yang, Chun-feng Wang, Jing Ding, Ji-yu Li.   

Abstract

OBJECTIVE AND
DESIGN: Mast cell (MC) degranulation can break peripheral immune tolerance. However, its mechanism remains unclear. Our goal was to study the stabilization of MC membranes by heme oxygenase-1 (HO-1) in order to influence dendritic cell (DC) function. MATERIAL: Mast cells and dendritic cells were prepared from 8-week-old to 10-week-old C57BL/6 mice; spleen mononuclear cells (SMCs) were prepared from 8-week-old to 10-week-old C57BL/6 and Balb/c mice. TREATMENT: Mast cells were pretreated with PBS, DMSO, Hemin (50 μl/ml), and Znpp (50 μl/ml) for 8 h.
METHOD: Real-time PCR and western-blot tested the HO-1 of MC mRNA and protein. The co-stimulatory molecules of DCs (CD80, CD86, CD40) were measured by flow cytometry, and levels of TNF-α, IL-6, and IFN-γ were measured by ELISA. We set up a one-way mixed lymphocyte reaction (MLR) model to test the proliferation of SMCs after MC/DC interaction. *P < 0.05 (t test) was taken as the level of statistical significance. RESULT: MCs pretreated with hemin induced HO-1 mRNA and protein expression, then interacted with DCs; expression of the co-stimulatory molecules was attenuated. The TNF-α, IL-6, and IFN-γ levels in the co-culture system were decreased. These DCs couldn't stimulate the proliferation of SMCs.
CONCLUSION: Inhibiting MC degranulation by HO-1 restrained DC maturation and attenuated the proliferation of SMCs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24604352     DOI: 10.1007/s00011-014-0722-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  34 in total

1.  Allergy.

Authors:  S J Galli
Journal:  Curr Biol       Date:  2000-02-10       Impact factor: 10.834

2.  Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo.

Authors:  Dimitris Skokos; Hany Goubran Botros; Christian Demeure; Joelle Morin; Roger Peronet; Gerd Birkenmeier; Sarah Boudaly; Salaheddine Mécheri
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

3.  Exogenous dendritic cell homing to draining lymph nodes can be boosted by mast cell degranulation.

Authors:  Shu-Rong Ren; Li-Bin Xu; Zhi-Yuan Wu; Jun Du; Mei-Hua Gao; Chun-Feng Qu
Journal:  Cell Immunol       Date:  2010-04-04       Impact factor: 4.868

Review 4.  Mast cells as modulators of T-cell responses.

Authors:  Blayne Amir Sayed; Melissa A Brown
Journal:  Immunol Rev       Date:  2007-06       Impact factor: 12.988

5.  Type I IFN regulate DC turnover in vivo.

Authors:  Fabrizio Mattei; Laura Bracci; David F Tough; Filippo Belardelli; Giovanna Schiavoni
Journal:  Eur J Immunol       Date:  2009-07       Impact factor: 5.532

6.  Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis.

Authors:  Kathrin Hochegger; Frank Siebenhaar; Volker Vielhauer; Dorothea Heininger; Tanya N Mayadas; Gert Mayer; Marcus Maurer; Alexander R Rosenkranz
Journal:  Eur J Immunol       Date:  2005-10       Impact factor: 5.532

Review 7.  Mast cells in the development of adaptive immune responses.

Authors:  Stephen J Galli; Susumu Nakae; Mindy Tsai
Journal:  Nat Immunol       Date:  2005-02       Impact factor: 25.606

8.  Mast cells are essential intermediaries in regulatory T-cell tolerance.

Authors:  Li-Fan Lu; Evan F Lind; David C Gondek; Kathy A Bennett; Michael W Gleeson; Karina Pino-Lagos; Zachary A Scott; Anthony J Coyle; Jennifer L Reed; Jacques Van Snick; Terry B Strom; Xin Xiao Zheng; Randolph J Noelle
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

9.  Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands.

Authors:  Salima Mrabet-Dahbi; Martin Metz; Anne Dudeck; Torsten Zuberbier; Marcus Maurer
Journal:  Exp Dermatol       Date:  2009-05       Impact factor: 3.960

10.  Heme oxygenase-1 mediated cytoprotection against liver ischemia and reperfusion injury: inhibition of type-1 interferon signaling.

Authors:  Sei-ichiro Tsuchihashi; Yuan Zhai; Qiao Bo; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Transplantation       Date:  2007-06-27       Impact factor: 4.939

View more
  4 in total

Review 1.  Effects of heme oxygenase-1 on innate and adaptive immune responses promoting pregnancy success and allograft tolerance.

Authors:  Anne Schumacher; Ana C Zenclussen
Journal:  Front Pharmacol       Date:  2015-01-06       Impact factor: 5.810

2.  Polydatin inhibits mast cell-mediated allergic inflammation by targeting PI3K/Akt, MAPK, NF-κB and Nrf2/HO-1 pathways.

Authors:  Jing Ye; Hongmei Piao; Jingzhi Jiang; Guangyu Jin; Mingyu Zheng; Jinshi Yang; Xiang Jin; Tianyi Sun; Yun Ho Choi; Liangchang Li; Guanghai Yan
Journal:  Sci Rep       Date:  2017-09-19       Impact factor: 4.379

3.  7-O-Methylluteolin Suppresses the 2,4-Dinitrochlorobenzene-Induced Nrf2/HO-1 Pathway and Atopic Dermatitis-like Lesions.

Authors:  Tae-Young Kim; No-June Park; Beom-Geun Jo; Jin-Hyub Paik; Sangho Choi; Su-Nam Kim; Min Hye Yang
Journal:  Antioxidants (Basel)       Date:  2022-07-08

Review 4.  Immune Regulation of Heme Oxygenase-1 in Allergic Airway Inflammation.

Authors:  Zhenwei Xia; Wenwei Zhong
Journal:  Antioxidants (Basel)       Date:  2022-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.